U.S. Industrials Stock News

NYSE:WK
NYSE:WKSoftware

Is Workiva (WK) Now An Opportunity After Prolonged Share Price Weakness?

If you are wondering whether Workiva's current share price reflects its true worth, you are not alone. This article walks through what that could mean for long term holders and for new investors looking at the stock for the first time. Workiva's shares last closed at US$61.93, with returns of an 11.5% decline over 7 days, 27.8% decline over 30 days, 25.4% decline year to date and 31.0% decline over 1 year, while the 3 year and 5 year returns are 27.6% decline and 39.8% decline...
NasdaqGS:MTSI
NasdaqGS:MTSISemiconductor

MACOM Gains Attention As Growth Story Meets Rich Valuation Debate

Aristotle Capital Boston identified MACOM Technology Solutions Holdings (NasdaqGS:MTSI) as a leading contributor in its portfolio. The firm credited MACOM's quarterly results, recent acquisitions, and demand in data center and 5G markets for this performance. This recognition reflects institutional attention on MACOM's position across key communications and infrastructure end markets. MACOM Technology Solutions focuses on semiconductor products used in data centers, telecom networks, and 5G...
NYSE:DXC
NYSE:DXCIT

DXC Expands AI Capabilities And Insurance Platforms With London Centre And Hiring

DXC Technology (NYSE:DXC) has opened a new Customer Experience Centre in London focused on helping clients scale AI solutions. The company is recruiting 150 AI specialists across the UK and Ireland to support growing demand for AI projects. DXC is expanding its partnership with PoloWorks to support digital onboarding of new Lloyd's syndicates via its Assure Commercial & Specialty platform. DXC Technology sits at the intersection of IT services and sector specific platforms, so moves like a...
NYSE:UE
NYSE:UERetail REITs

Urban Edge Dividend Hike Raises Questions On Earnings And Coverage Risks

Urban Edge Properties (NYSE:UE) announced an 11% increase to its annual dividend. The higher dividend was approved by the board as part of its latest capital return decision. For investors watching NYSE:UE, the dividend hike comes with the shares trading around $20.77. The stock has logged a 9.5% return over the past 30 days and an 8.7% return year to date, with a 52.3% return over three years and 47.7% over five years. This mix of recent and multiyear performance provides useful context...
NasdaqGS:PAX
NasdaqGS:PAXCapital Markets

Patria Expands Platform With New Acquisitions And Latin America Credit Push

Patria Investments (NasdaqGS:PAX) has agreed to acquire majority stakes in Brazil based Solis Investimentos, Share Student Living, and WP Global Partners. The transactions expand Patria's reach in structured credit, student housing, and North American middle market investment solutions. Alongside these acquisitions, Patria is launching a new private credit strategy focused on Latin America. Patria Investments, a Latin America focused alternative asset manager listed as NasdaqGS:PAX, is...
NYSE:EQBK
NYSE:EQBKBanks

Insider-Owned Growth Companies That Could Transform Your Portfolio

As the U.S. stock market kicks off February with a strong performance, highlighted by significant gains in major indices like the Dow Jones and S&P 500, investors are keenly observing how economic policies and international trade developments might influence future trends. In this dynamic environment, companies with high insider ownership often draw attention for their potential to align management interests with shareholder value, making them intriguing candidates for those looking to...
OTCPK:RDGL
OTCPK:RDGLMedical Equipment

Gaia Leads The Charge With 2 Other Promising Penny Stocks

The U.S. stock market kicked off February with a strong performance, as major indexes like the Dow Jones and S&P 500 saw significant gains. Amidst this backdrop of market optimism, investors are increasingly exploring opportunities beyond the well-known giants. Penny stocks, though often considered niche investments, continue to capture interest due to their potential for growth in smaller or newer companies. While the term may seem outdated, these stocks can still present compelling...
NasdaqCM:VFF
NasdaqCM:VFFFood

Exploring 3 Undiscovered Gems In The US Market

As the U.S. stock market kicks off February with a notable upswing, highlighted by the Dow's impressive 515-point gain and the S&P 500 nearing record highs, investors are keenly observing how economic indicators like factory activity expansion might influence small-cap stocks. In this dynamic environment, identifying promising yet overlooked opportunities can be crucial for portfolio diversification and potential growth. Exploring lesser-known stocks that align with current economic trends...
NasdaqGS:ACLX
NasdaqGS:ACLXBiotechs

Did Anito-cel’s D-Domain Safety Signal at Tandem Just Shift Arcellx's (ACLX) Investment Narrative?

Arcellx announced that a late-breaking abstract on its BCMA-directed CAR T therapy anitocabtagene autoleucel (anito-cel), featuring its novel D-Domain binder, was accepted and presented at the 2026 Tandem Meetings, highlighting preclinical data in relapsed or refractory multiple myeloma. The preclinical poster suggested that the compact D-Domain binder avoided tonic signaling and off-target activity seen with some other BCMA CAR constructs, potentially pointing to a differentiated safety...
NYSE:HIW
NYSE:HIWOffice REITs

Highwoods Properties (HIW) Valuation Check After US$300 Million At The Market Equity Offering

Highwoods Properties (HIW) has kicked off a US$300 million at the market follow-on equity offering, shortly after reporting its fourth quarter and full year 2025 earnings and outlining its acquisition and development plans. See our latest analysis for Highwoods Properties. The at the market program and recent earnings update come after a 16.05% 30 day share price decline and a 15.65% 1 year total shareholder return decline, while the 3 year total shareholder return is slightly positive,...
NYSE:ARI
NYSE:ARIMortgage REITs

What Apollo Commercial Real Estate Finance (ARI)'s Return To Full-Year Profitability Means For Shareholders

Apollo Commercial Real Estate Finance recently reported its fourth-quarter 2025 results, with net income of US$29.2 million and earnings per share of US$0.18, alongside full-year net income of US$126.72 million after a prior-year loss. The shift from a full-year net loss in the previous period to profitability in 2025 highlights a significant turnaround in the company’s earnings profile. Now, we’ll examine how this move back to full-year profitability reshapes Apollo Commercial Real Estate...
NasdaqGS:RNW
NasdaqGS:RNWRenewable Energy

ReNew Energy Global (NasdaqGS:RNW) Returns To Quarterly Loss And Tests Bullish Profitability Narrative

ReNew Energy Global (NasdaqGS:RNW) just posted Q3 2026 results with revenue of ₹25.1b and a small net loss of ₹198m, translating to basic EPS of ₹0.54 loss, setting a very different tone from the profits seen earlier in the year. The company has seen quarterly revenue move from ₹18.5b in Q3 2025 to ₹29.0b in Q4 2025, then to ₹39.0b in Q1 2026 and ₹36.3b in Q2 2026, with EPS swinging from a ₹10.70 loss in Q3 2025 to positive ₹6.91, ₹14.14 and ₹12.87 across those subsequent quarters before...
NYSE:CVI
NYSE:CVIOil and Gas

Is CVR Energy (CVI) Pricing Reflect Its DCF Upside After Recent Share Price Weakness

If you are wondering whether CVR Energy's current share price really lines up with its underlying worth, you are in the right place because this article focuses squarely on what the numbers say about value. The stock closed at US$23.17, with a 7 day return of 4.3% decline, a 30 day return of 0.6% decline, a year to date return of 8.0% decline, a 1 year return of 25.3%, a 3 year return of 12.8% decline and a 5 year return of 95.6%. Recent price moves sit against a backdrop of ongoing interest...
NasdaqGS:BBIO
NasdaqGS:BBIOBiotechs

Has BridgeBio Pharma (BBIO) Run Too Far After 112% One Year Share Price Surge?

If you are wondering whether BridgeBio Pharma's share price still reflects good value or has run too far, it helps to step back and look at what the current valuation is really telling you. The stock last closed at US$75.25, with a 3.8% gain over the past week, a 1.3% decline over the past month, a 3.8% decline year to date, and a 112% return over the last year, plus a very large return over three years that is more than 7x. These sharp moves have been accompanied by regular clinical and...